|
C3ORF10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.514000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.439600E-02 |
| Normal-vs-Stage2 |
1.009550E-02 |
| Normal-vs-Stage3 |
3.417100E-03 |
| Normal-vs-Stage4 |
9.624100E-02 |
| Stage1-vs-Stage2 |
1.903200E-01 |
| Stage1-vs-Stage3 |
3.783800E-02 |
| Stage1-vs-Stage4 |
1.903430E-01 |
| Stage2-vs-Stage3 |
6.423600E-01 |
| Stage2-vs-Stage4 |
7.487400E-01 |
| Stage3-vs-Stage4 |
9.776000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.634300E-02 |
| Normal-vs-AfricanAmerican |
5.378200E-02 |
| Normal-vs-Asian |
2.996400E-01 |
| Caucasian-vs-AfricanAmerican |
8.521800E-01 |
| Caucasian-vs-Asian |
9.171600E-01 |
| AfricanAmerican-vs-Asian |
9.642800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.539300E-03 |
| Normal-vs-Female |
9.808400E-01 |
| Male-vs-Female |
3.163000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.214000E-02 |
| Normal-vs-Extreme_Weight |
1.968230E-02 |
| Normal-vs-Obese |
8.486400E-02 |
| Normal-vs-Extreme_Obese |
1.263030E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.722000E-01 |
| Normal_Weight-vs-Obese |
5.118600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.265400E-01 |
| Extreme_Weight-vs-Obese |
6.344000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.691200E-01 |
| Obese-vs-Extreme_Obese |
3.588400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.665400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.404500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.147600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.535800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.405400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.504000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.830800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.937200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.553000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.549000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.003800E-01 |
| Normal-VS-Type2 PRCC |
1.59781999999886E-05 |
| Normal-VS-KIRP CIMP |
8.960600E-01 |
| Normal-VS-Unclassified PRCC |
1.038210E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.80799999999404E-06 |
| Type1 PRCC-VS-KIRP CIMP |
8.508600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.541900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.306100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.454000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.460810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.496600E-03 |
| Normal-vs-N1 |
3.94400000000017E-05 |
| Normal-vs-N2 |
4.967800E-01 |
| N0-vs-N1 |
1.783240E-01 |
| N0-vs-N2 |
1.001180E-01 |
| N1-vs-N2 |
2.441700E-02 |
|
|
